Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis
Microbial Pathogenesis · 2024
DOI: 10.1016/j.micpath.2024.106730 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Umang Mudgil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Panjab University, Chandigarh, India. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Pseudomonas Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 133 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Panjab University, Chandigarh, India.
- Department of Microbiology, Panjab University, Chandigarh, India. Electronic address: kusumharjai@pu.ac.in.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Mudgil, U., Khullar, L., Chadha, J., Prerna, & Harjai, K. (2024). Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2024.106730
Vancouver
Mudgil U, Khullar L, Chadha J, Prerna, Harjai K. Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2024.106730
BibTeX
@article{Mudgil2024,
author = {Mudgil, Umang and Khullar, Lavanya and Chadha, Jatin and Prerna and Harjai, Kusum},
title = {Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis},
journal = {Microbial Pathogenesis},
year = {2024},
doi = {10.1016/j.micpath.2024.106730}
}
EUVIMED